Follow
Emad B. Basalious
Emad B. Basalious
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University
Verified email at pharma.cu.edu.eg - Homepage
Title
Cited by
Cited by
Year
SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization
EB Basalious, N Shawky, SM Badr-Eldin
International journal of pharmaceutics 391 (1-2), 203-211, 2010
3402010
Fluconazole mucoadhesive buccal films: in vitro/in vivo performance
SA Yehia, ON El-Gazayerly, EB Basalious
Current drug delivery 6 (1), 17-27, 2009
1382009
Fluconazole mucoadhesive buccal films: in vitro/in vivo performance
SA Yehia, ON El-Gazayerly, EB Basalious
Current drug delivery 6 (1), 17-27, 17-27, 2009
1382009
Formulation and evaluation of diclofenac sodium buccoadhesive discs
MS El-Samaligy, SA Yahia, EB Basalious
International Journal of Pharmaceutics 286 (1-2), 27-39, 2004
1382004
Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation
SA Fouad, EB Basalious, MA El-Nabarawi, SA Tayel
International journal of pharmaceutics 453 (2), 569-578, 2013
1322013
Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study
MR Rezk, EB Basalious, IA Karim
Journal of pharmaceutical and biomedical analysis 114, 97-104, 2015
1062015
Pharmaceutical nanotechnology: from the bench to the market
ZM Mazayen, AM Ghoneim, RS Elbatanony, EB Basalious, ER Bendas
Future journal of pharmaceutical sciences 8 (1), 12, 2022
892022
Development and validation of sensitive and rapid UPLC–MS/MS method for quantitative determination of daclatasvir in human plasma: Application to a bioequivalence study
MR Rezk, ER Bendas, EB Basalious, IA Karim
Journal of pharmaceutical and biomedical analysis 128, 61-66, 2016
842016
Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors …
EB Basalious, W El-Sebaie, O El-Gazayerly
Aaps Pharmscitech 12, 799-810, 2011
822011
Design and In Vitro/In Vivo Evaluation of Novel Mucoadhesive Buccal Discs of an Antifungal Drug: Relationship Between Swelling, Erosion, and Drug Release
SA Yehia, ON El-Gazayerly, EB Basalious
Aaps Pharmscitech 9, 1207-1217, 2008
742008
Quantification of sofosbuvir and ledipasvir in human plasma by UPLC–MS/MS method: Application to fasting and fed bioequivalence studies
MR Rezk, ER Bendas, EB Basalious, IA Karim
Journal of Chromatography B 1028, 63-70, 2016
702016
Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery
HM El-Laithy, EB Basalious, BM El-Hoseiny, MM Adel
International journal of pharmaceutics 490 (1-2), 146-154, 2015
642015
Novel and sensitive UPLC–MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study
MR Rezk, EB Basalious, ME Amin
Biomedical chromatography 30 (9), 1354-1362, 2016
622016
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo …
EB Basalious, RN Shamma
International journal of pharmaceutics 493 (1-2), 347-356, 2015
602015
In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in …
FS Abdel-Salam, SA Elkheshen, AA Mahmoud, EB Basalious, MS Amer, ...
International journal of pharmaceutics 580, 119213, 2020
422020
Optimization and In vivo Pharmacokinetic Study of a Novel Controlled Release Venlafaxine Hydrochloride Three-Layer Tablet
AA Aboelwafa, EB Basalious
Aaps Pharmscitech 11, 1026-1037, 2010
422010
Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution …
HM Rashed, RN Shamma, EB Basalious
Drug delivery 24 (1), 181-187, 2017
382017
Long lasting in-situ forming implant loaded with raloxifene HCl: an injectable delivery system for treatment of bone injuries
NA Elkasabgy, FS Abdel-Salam, AA Mahmoud, EB Basalious, MS Amer, ...
International journal of pharmaceutics 571, 118703, 2019
362019
Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies
EB Basalious, W El-Sebaie, O El-Gazayerly
Pharmaceutical Development and Technology 18 (2), 407-416, 2013
362013
Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC–MS/MS method: Application to a bioequivalence study
MR Rezk, EB Basalious, KA Badr
Biomedical Chromatography 32 (11), e4347, 2018
352018
The system can't perform the operation now. Try again later.
Articles 1–20